info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Biologics Market Research Report By Product Type (Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Recombinant Proteins, Hormones), By Application (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Neurological Disorders), By End User (Hospitals, Pharmaceutical Companies, Research Institutes, Diagnostics Laboratories), By Source (Microbial, Mammalian, Plant, Transgenic Animals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035


ID: MRFR/HC/0831-CR | 138 Pages | Author: Rahul Gotadki| December 2018

Biologics Market Segmentation




  • Biologics Market By Product Type (USD Billion, 2019-2035)




    • Monoclonal Antibodies




    • Vaccines




    • Cell and Gene Therapy




    • Recombinant Proteins




    • Hormones








  • Biologics Market By Application (USD Billion, 2019-2035)




    • Oncology




    • Infectious Diseases




    • Autoimmune Disorders




    • Cardiovascular Diseases




    • Neurological Disorders






 




  • Biologics Market By End User (USD Billion, 2019-2035)




    • Hospitals




    • Pharmaceutical Companies




    • Research Institutes




    • Diagnostics Laboratories






 




  • Biologics Market By Source (USD Billion, 2019-2035)




    • Microbial




    • Mammalian




    • Plant




    • Transgenic Animals






 




  • Biologics Market By Regional (USD Billion, 2019-2035)




    • North America




    • Europe




    • South America




    • Asia Pacific




    • Middle East and Africa






 


Biologics Market Regional Outlook (USD Billion, 2019-2035)


 


 




  • North America Outlook (USD Billion, 2019-2035)




    • North America Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • North America Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • North America Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • North America Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • North America Biologics Market by Regional Type




      • US




      • Canada






    • US Outlook (USD Billion, 2019-2035)




    • US Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • US Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • US Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • US Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • CANADA Outlook (USD Billion, 2019-2035)




    • CANADA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • CANADA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • CANADA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • CANADA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals








  • Europe Outlook (USD Billion, 2019-2035)




    • Europe Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • Europe Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • Europe Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • Europe Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • Europe Biologics Market by Regional Type




      • Germany




      • UK




      • France




      • Russia




      • Italy




      • Spain




      • Rest of Europe






    • GERMANY Outlook (USD Billion, 2019-2035)




    • GERMANY Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • GERMANY Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • GERMANY Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • GERMANY Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • UK Outlook (USD Billion, 2019-2035)




    • UK Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • UK Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • UK Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • UK Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • FRANCE Outlook (USD Billion, 2019-2035)




    • FRANCE Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • FRANCE Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • FRANCE Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • FRANCE Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • RUSSIA Outlook (USD Billion, 2019-2035)




    • RUSSIA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • RUSSIA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • RUSSIA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • RUSSIA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • ITALY Outlook (USD Billion, 2019-2035)




    • ITALY Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • ITALY Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • ITALY Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • ITALY Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • SPAIN Outlook (USD Billion, 2019-2035)




    • SPAIN Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • SPAIN Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • SPAIN Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • SPAIN Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • REST OF EUROPE Outlook (USD Billion, 2019-2035)




    • REST OF EUROPE Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • REST OF EUROPE Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • REST OF EUROPE Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • REST OF EUROPE Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals








  • APAC Outlook (USD Billion, 2019-2035)




    • APAC Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • APAC Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • APAC Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • APAC Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • APAC Biologics Market by Regional Type




      • China




      • India




      • Japan




      • South Korea




      • Malaysia




      • Thailand




      • Indonesia




      • Rest of APAC






    • CHINA Outlook (USD Billion, 2019-2035)




    • CHINA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • CHINA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • CHINA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • CHINA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • INDIA Outlook (USD Billion, 2019-2035)




    • INDIA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • INDIA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • INDIA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • INDIA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • JAPAN Outlook (USD Billion, 2019-2035)




    • JAPAN Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • JAPAN Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • JAPAN Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • JAPAN Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • SOUTH KOREA Outlook (USD Billion, 2019-2035)




    • SOUTH KOREA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • SOUTH KOREA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • SOUTH KOREA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • SOUTH KOREA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • MALAYSIA Outlook (USD Billion, 2019-2035)




    • MALAYSIA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • MALAYSIA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • MALAYSIA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • MALAYSIA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • THAILAND Outlook (USD Billion, 2019-2035)




    • THAILAND Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • THAILAND Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • THAILAND Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • THAILAND Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • INDONESIA Outlook (USD Billion, 2019-2035)




    • INDONESIA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • INDONESIA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • INDONESIA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • INDONESIA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • REST OF APAC Outlook (USD Billion, 2019-2035)




    • REST OF APAC Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • REST OF APAC Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • REST OF APAC Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • REST OF APAC Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals








  • South America Outlook (USD Billion, 2019-2035)




    • South America Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • South America Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • South America Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • South America Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • South America Biologics Market by Regional Type




      • Brazil




      • Mexico




      • Argentina




      • Rest of South America






    • BRAZIL Outlook (USD Billion, 2019-2035)




    • BRAZIL Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • BRAZIL Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • BRAZIL Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • BRAZIL Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • MEXICO Outlook (USD Billion, 2019-2035)




    • MEXICO Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • MEXICO Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • MEXICO Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • MEXICO Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • ARGENTINA Outlook (USD Billion, 2019-2035)




    • ARGENTINA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • ARGENTINA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • ARGENTINA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • ARGENTINA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)




    • REST OF SOUTH AMERICA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • REST OF SOUTH AMERICA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • REST OF SOUTH AMERICA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • REST OF SOUTH AMERICA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals








  • MEA Outlook (USD Billion, 2019-2035)




    • MEA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • MEA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • MEA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • MEA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • MEA Biologics Market by Regional Type




      • GCC Countries




      • South Africa




      • Rest of MEA






    • GCC COUNTRIES Outlook (USD Billion, 2019-2035)




    • GCC COUNTRIES Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • GCC COUNTRIES Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • GCC COUNTRIES Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • GCC COUNTRIES Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • SOUTH AFRICA Outlook (USD Billion, 2019-2035)




    • SOUTH AFRICA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • SOUTH AFRICA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • SOUTH AFRICA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • SOUTH AFRICA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals






    • REST OF MEA Outlook (USD Billion, 2019-2035)




    • REST OF MEA Biologics Market by Product Type




      • Monoclonal Antibodies




      • Vaccines




      • Cell and Gene Therapy




      • Recombinant Proteins




      • Hormones






    • REST OF MEA Biologics Market by Application Type




      • Oncology




      • Infectious Diseases




      • Autoimmune Disorders




      • Cardiovascular Diseases




      • Neurological Disorders






    • REST OF MEA Biologics Market by End User Type




      • Hospitals




      • Pharmaceutical Companies




      • Research Institutes




      • Diagnostics Laboratories






    • REST OF MEA Biologics Market by Source Type




      • Microbial




      • Mammalian




      • Plant




      • Transgenic Animals








 


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. BIOLOGICS MARKET, BY PRODUCT TYPE (USD BILLION)

6.1. Monoclonal Antibodies

6.2. Vaccines

6.3. Cell and Gene Therapy

6.4. Recombinant Proteins

6.5. Hormones

7. BIOLOGICS MARKET, BY APPLICATION (USD BILLION)

7.1. Oncology

7.2. Infectious Diseases

7.3. Autoimmune Disorders

7.4. Cardiovascular Diseases

7.5. Neurological Disorders

8. BIOLOGICS MARKET, BY END USER (USD BILLION)

8.1. Hospitals

8.2. Pharmaceutical Companies

8.3. Research Institutes

8.4. Diagnostics Laboratories

9. BIOLOGICS MARKET, BY SOURCE (USD BILLION)

9.1. Microbial

9.2. Mammalian

9.3. Plant

9.4. Transgenic Animals

10. BIOLOGICS MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Biologics Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Biologics Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Genentech

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Pfizer

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. AbbVie

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. Roche

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Gilead Sciences

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Johnson and Johnson

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. Bristol Myers Squibb

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. Eli Lilly

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Biogen

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. Celgene

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Novartis

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. Merck

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Regeneron

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. Amgen

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

12.15. Sanofi

12.15.1. Financial Overview

12.15.2. Products Offered

12.15.3. Key Developments

12.15.4. SWOT Analysis

12.15.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 3. NORTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 4. NORTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 5. NORTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 6. NORTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 7. US BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 8. US BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 9. US BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 10. US BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 11. US BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 12. CANADA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 13. CANADA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 14. CANADA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 15. CANADA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 16. CANADA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 17. EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 18. EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 19. EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 20. EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 21. EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 22. GERMANY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 23. GERMANY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 24. GERMANY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 25. GERMANY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 26. GERMANY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 27. UK BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 28. UK BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 29. UK BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 30. UK BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 31. UK BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 32. FRANCE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 33. FRANCE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 34. FRANCE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 35. FRANCE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 36. FRANCE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 37. RUSSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 38. RUSSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 39. RUSSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 40. RUSSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 41. RUSSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 42. ITALY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 43. ITALY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 44. ITALY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 45. ITALY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 46. ITALY BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 47. SPAIN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 48. SPAIN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 49. SPAIN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 50. SPAIN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 51. SPAIN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 52. REST OF EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 53. REST OF EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 54. REST OF EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 55. REST OF EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 56. REST OF EUROPE BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 57. APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 58. APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 59. APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 60. APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 61. APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 62. CHINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 63. CHINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 64. CHINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 65. CHINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 66. CHINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 67. INDIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 68. INDIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 69. INDIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 70. INDIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 71. INDIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 72. JAPAN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 73. JAPAN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 74. JAPAN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 75. JAPAN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 76. JAPAN BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 77. SOUTH KOREA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 78. SOUTH KOREA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 79. SOUTH KOREA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 80. SOUTH KOREA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 81. SOUTH KOREA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 82. MALAYSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 83. MALAYSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 84. MALAYSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 85. MALAYSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 86. MALAYSIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 87. THAILAND BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 88. THAILAND BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 89. THAILAND BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 90. THAILAND BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 91. THAILAND BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 92. INDONESIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 93. INDONESIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 94. INDONESIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 95. INDONESIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 96. INDONESIA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 97. REST OF APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 98. REST OF APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 99. REST OF APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 100. REST OF APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 101. REST OF APAC BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 102. SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 103. SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 104. SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 105. SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 106. SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 107. BRAZIL BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 108. BRAZIL BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 109. BRAZIL BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 110. BRAZIL BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 111. BRAZIL BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 112. MEXICO BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 113. MEXICO BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 114. MEXICO BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 115. MEXICO BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 116. MEXICO BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 117. ARGENTINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 118. ARGENTINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 119. ARGENTINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 120. ARGENTINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 121. ARGENTINA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 127. MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 128. MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 129. MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 130. MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 131. MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 132. GCC COUNTRIES BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 133. GCC COUNTRIES BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 134. GCC COUNTRIES BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 135. GCC COUNTRIES BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 136. GCC COUNTRIES BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 137. SOUTH AFRICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 138. SOUTH AFRICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 139. SOUTH AFRICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 140. SOUTH AFRICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 141. SOUTH AFRICA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 142. REST OF MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)

TABLE 143. REST OF MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)

TABLE 144. REST OF MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)

TABLE 145. REST OF MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD BILLIONS)

TABLE 146. REST OF MEA BIOLOGICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA BIOLOGICS MARKET ANALYSIS

FIGURE 3. US BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 4. US BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 5. US BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 6. US BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 7. US BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 9. CANADA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 10. CANADA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 11. CANADA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 12. CANADA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE BIOLOGICS MARKET ANALYSIS

FIGURE 14. GERMANY BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 15. GERMANY BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 16. GERMANY BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 17. GERMANY BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 18. GERMANY BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 20. UK BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 21. UK BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 22. UK BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 23. UK BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 25. FRANCE BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 26. FRANCE BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 27. FRANCE BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 28. FRANCE BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 30. RUSSIA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 31. RUSSIA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 32. RUSSIA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 33. RUSSIA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 35. ITALY BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 36. ITALY BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 37. ITALY BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 38. ITALY BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 40. SPAIN BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 41. SPAIN BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 42. SPAIN BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 43. SPAIN BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 45. REST OF EUROPE BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 46. REST OF EUROPE BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 47. REST OF EUROPE BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 48. REST OF EUROPE BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC BIOLOGICS MARKET ANALYSIS

FIGURE 50. CHINA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 51. CHINA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 52. CHINA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 53. CHINA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 54. CHINA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 56. INDIA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 57. INDIA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 58. INDIA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 59. INDIA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 61. JAPAN BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 62. JAPAN BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 63. JAPAN BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 64. JAPAN BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 66. SOUTH KOREA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 67. SOUTH KOREA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 68. SOUTH KOREA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 69. SOUTH KOREA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 71. MALAYSIA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 72. MALAYSIA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 73. MALAYSIA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 74. MALAYSIA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 76. THAILAND BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 77. THAILAND BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 78. THAILAND BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 79. THAILAND BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 81. INDONESIA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 82. INDONESIA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 83. INDONESIA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 84. INDONESIA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 86. REST OF APAC BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 87. REST OF APAC BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 88. REST OF APAC BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 89. REST OF APAC BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA BIOLOGICS MARKET ANALYSIS

FIGURE 91. BRAZIL BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 92. BRAZIL BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 93. BRAZIL BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 94. BRAZIL BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 95. BRAZIL BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 97. MEXICO BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 98. MEXICO BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 99. MEXICO BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 100. MEXICO BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 102. ARGENTINA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 103. ARGENTINA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 104. ARGENTINA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 105. ARGENTINA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 107. REST OF SOUTH AMERICA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 108. REST OF SOUTH AMERICA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 109. REST OF SOUTH AMERICA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 110. REST OF SOUTH AMERICA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA BIOLOGICS MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 113. GCC COUNTRIES BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 114. GCC COUNTRIES BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 115. GCC COUNTRIES BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 116. GCC COUNTRIES BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 118. SOUTH AFRICA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 119. SOUTH AFRICA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 120. SOUTH AFRICA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 121. SOUTH AFRICA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA BIOLOGICS MARKET ANALYSIS BY PRODUCT TYPE

FIGURE 123. REST OF MEA BIOLOGICS MARKET ANALYSIS BY APPLICATION

FIGURE 124. REST OF MEA BIOLOGICS MARKET ANALYSIS BY END USER

FIGURE 125. REST OF MEA BIOLOGICS MARKET ANALYSIS BY SOURCE

FIGURE 126. REST OF MEA BIOLOGICS MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF BIOLOGICS MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF BIOLOGICS MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: BIOLOGICS MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: BIOLOGICS MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: BIOLOGICS MARKET

FIGURE 133. BIOLOGICS MARKET, BY PRODUCT TYPE, 2025 (% SHARE)

FIGURE 134. BIOLOGICS MARKET, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)

FIGURE 135. BIOLOGICS MARKET, BY APPLICATION, 2025 (% SHARE)

FIGURE 136. BIOLOGICS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)

FIGURE 137. BIOLOGICS MARKET, BY END USER, 2025 (% SHARE)

FIGURE 138. BIOLOGICS MARKET, BY END USER, 2019 TO 2035 (USD Billions)

FIGURE 139. BIOLOGICS MARKET, BY SOURCE, 2025 (% SHARE)

FIGURE 140. BIOLOGICS MARKET, BY SOURCE, 2019 TO 2035 (USD Billions)

FIGURE 141. BIOLOGICS MARKET, BY REGIONAL, 2025 (% SHARE)

FIGURE 142. BIOLOGICS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
report-img